Online citations, reference lists, and bibliographies.
← Back to Search

Role Of Imaging In Diagnosis, Staging And Follow-up Of Lung Cancer

W. De Wever, J. Verschakelen, J. Coolen
Published 2014 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Purpose of review Primary lung cancer is still the number one cause of cancer death worldwide. Screening, detection and staging of lung cancer are important because the only potentially curative therapy today is surgical resection of early-stage lung cancer. Recent findings Different imaging techniques can be used in these different processes. Recent advances in computed tomography (CT) technology have allowed investigation of novel methods for the evaluation of lung cancer. Recent advances in magnetic resonance technology and administration of contrast media have further improved the image quality and diagnostic capability of magnetic resonance. Positron emission tomography (PET)/CT has been shown to be superior to stand-alone PET or CT in the evaluation of lymph nodes and in the detection of distant metastases. Summary The current recommended imaging required for lung cancer staging is CT of the thorax and PET/CT from skull base to mid-thigh. However, with the recent developments in the armamentarium of imaging techniques, the choice of one of these techniques can be directed by the presence of a technique in a local hospital and/or by the presence of an experienced person at that time.
This paper references
10.1177/0284185113481593
Digital tomosynthesis of the thorax: the influence of respiratory motion artifacts on lung nodule detection
S. Kim (2013)
Image quality assessment of standard- and low-dose chest CT using filtered back projection, adaptive statistical iterative reconstruction, and novel model-based iterative recon- struction algorithms
V Vardhanabhuti (2013)
10.1148/RADIOL.2372041887
Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner Society.
H. MacMahon (2005)
10.1016/j.jacr.2013.09.013
Controversies in lung cancer screening.
R. Gill (2013)
Nonsmall cell lung cancer: whole-body MR examination for M-stage assessment: utility for whole-body diffusion-weighted imaging compared with integrated FDG PET/CT
Y Ohno (2008)
10.1097/RTI.0000000000000062
Positron Emission Tomography/Magnetic Resonance Imaging Evaluation of Lung Cancer: Current Status and Future Prospects
S. H. Yoon (2014)
10.1016/J.LUNGCAN.2007.08.036
Lymph node staging by means of positron emission tomography is less accurate in non-small cell lung cancer patients with enlarged lymph nodes: analysis of 1,145 lymph nodes.
N. Al-Sarraf (2008)
10.1007/s00330-012-2765-y
Iterative reconstruction techniques for computed tomography Part 1: Technical principles
M. Willemink (2012)
10.1007/s00330-013-3053-1
Characterisation of solitary pulmonary lesions combining visual perfusion and quantitative diffusion MR imaging
J. Coolen (2013)
10.7326/0003-4819-159-6-201309170-00690
Screening for Lung Cancer With Low-Dose Computed Tomography: A Systematic Review to Update the U.S. Preventive Services Task Force Recommendation
L. Humphrey (2013)
10.1056/NEJMoa1209120
Results of initial low-dose computed tomographic screening for lung cancer.
T. Church (2013)
In this article, the potential of dual-energy CT techniques for the detection, characterization, staging and surveillance of chest malignancy
L J Zhang (2013)
10.1016/j.crad.2012.05.018
Post-processing applications in thoracic computed tomography.
S. Walsh (2013)
10.1148/RADIOL.2331031535
Solitary pulmonary nodules: dynamic enhanced multi-detector row CT study and comparison with vascular endothelial growth factor and microvessel density.
C. Yi (2004)
Value of PET / CT versus enhanced CT for locoregional lymph nodes in nonsmall cell
J Yu (2008)
10.1016/j.acra.2012.12.009
Digital tomosynthesis as a problem-solving imaging technique to confirm or exclude potential thoracic lesions based on chest X-ray radiography.
E. Quaia (2013)
10.1102/1470-7330.2013.9025
Incidental, subsolid pulmonary nodules at CT: etiology and management
Jessica Seidelman (2013)
10.1016/j.lungcan.2007.11.007
Value of PET/CT versus enhanced CT for locoregional lymph nodes in non-small cell lung cancer.
W. Yang (2008)
10.1200/JCO.2003.07.054
Positron emission tomography is superior to computed tomography scanning for response-assessment after radical radiotherapy or chemoradiotherapy in patients with non-small-cell lung cancer.
M. M. Mac Manus (2003)
10.1378/chest.12-1487
A practical algorithmic approach to the diagnosis and management of solitary pulmonary nodules: part 2: pretest probability and algorithm.
V. Patel (2013)
In this article, we can find a good overview of the potential of magnetic resonance technique for lung cancer evaluation
Recommendations for the management of subsolid pulmonary nodules detected at CT: a statement from the Fleischner Society
DP Naidich (2013)
10.1097/RTI.0b013e318173dd38
Dual Energy Subtraction and Temporal Subtraction Chest Radiography
H. MacMahon (2008)
10.1055/S-2001-16201
[Meta-analysis of the efficacy of positron emission tomography with F-18-fluorodeoxyglucose in lung tumors. Basis for discussion of the German Consensus Conference on PET in Oncology 2000].
D. Hellwig (2001)
10.1148/radiol.2492071956
Clinical utility of dual-energy CT in the evaluation of solitary pulmonary nodules: initial experience.
E. J. Chae (2008)
Lymph node staging by means of positron emission tomography is less accurate in nonsmall cell
N Al-Sarraf
10.1200/JCO.2012.43.3110
Computed tomography screening for lung cancer: has it finally arrived? Implications of the national lung screening trial.
D. Aberle (2013)
Management strategy of pulmonary nodule
M Lederlin (2013)
10.1148/radiol.13130620
Pulmonary nodules in patients with primary malignancy: comparison of hybrid PET/MR and PET/CT imaging.
H. Chandarana (2013)
10.1001/JAMA.285.7.914
Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis.
M. Gould (2001)
10.1177/0284185113498536
Diagnostic efficacy of PET and PET/CT for recurrent lung cancer: a meta-analysis
Y. He (2014)
10.1148/RADIOL.2413051535
Recent advances in chest radiography.
H. McAdams (2006)
10.5152/dir.2014.13401
Comparison of emergency cranial CT interpretation between radiology residents and neuroradiologists: transverse versus three-dimensional images.
Eun Soo Kim (2014)
10.1378/CHEST.07-1656
Ultrasound vs. CT in detecting chest wall invasion by tumor: a prospective study.
V. Bandi (2008)
10.1016/J.EJRAD.2005.04.002
Thin-section multiplanar reformats from multidetector-row CT data: utility for assessment of regional tumor extent in non-small cell lung cancer.
T. Higashino (2005)
10.1007/s00330-012-2542-y
Preoperative staging of non-small-cell lung cancer: comparison of whole-body diffusion-weighted magnetic resonance imaging and 18F-fluorodeoxyglucose-positron emission tomography/computed tomography
G. Sommer (2012)
10.1378/chest.12-0960
A practical algorithmic approach to the diagnosis and management of solitary pulmonary nodules: part 1: radiologic characteristics and imaging modalities.
V. Patel (2013)
10.1148/radiol.2482072039
Non-small cell lung cancer: whole-body MR examination for M-stage assessment--utility for whole-body diffusion-weighted imaging compared with integrated FDG PET/CT.
Y. Ohno (2008)
10.2214/AJR.12.9424
Image quality assessment of standard- and low-dose chest CT using filtered back projection, adaptive statistical iterative reconstruction, and novel model-based iterative reconstruction algorithms.
V. Vardhanabhuti (2013)
Hybrid [18F]-FDG PET/MRI including non-Gaussian diffusion-weighted imaging (DWI): preliminary results in non- small cell lung cancer (NSCLC)
P Heusch (2013)
10.1016/j.rcl.2013.08.007
The clinical staging of lung cancer through imaging: a radiologist's guide to the revised staging system and rationale for the changes.
S. Kligerman (2014)
10.1007/s00330-006-0284-4
Additional value of PET-CT in the staging of lung cancer: comparison with CT alone, PET alone and visual correlation of PET and CT
W. D. Wever (2006)
10.1378/CHEST.89.4_SUPPLEMENT.242S
Magnetic resonance imaging in lung cancer.
G. Gamsu (1986)
Positron emission tomography is superior to computed tomography scanning for response-assessment after radical radiotherapy or chemoradiotherapy in patients with nonsmall-cell lung cancer
MP Mac Manus (2003)
10.1148/radiol.2482071822
Non-small cell lung cancer staging: efficacy comparison of integrated PET/CT versus 3.0-T whole-body MR imaging.
C. Yi (2008)
10.3978/j.issn.2072-1439.2013.07.27
Modern diagnostic and therapeutic interventional radiology in lung cancer.
Wai-kit Lee (2013)
10.5152/dir.2013.12021
Non-small cell lung cancer after surgery and chemoradiotherapy: follow-up and response assessment.
D. Colombi (2013)
Methods for staging nonsmall cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines
GA Silvestri (2013)
10.1007/s13244-013-0247-7
PET/CT versus body coil PET/MRI: how low can you go?
P. Appenzeller (2013)
10.1097/RTI.0b013e3181f51e7f
ACR Appropriateness Criteria® noninvasive clinical staging of bronchogenic carcinoma.
J. Ravenel (2010)
10.5152/dir.2013.13223
Pulmonary subsolid nodules: what radiologists need to know about the imaging features and management strategy.
H. Kim (2014)
10.1148/radiol.12110872
Malignant pleural disease: diagnosis by using diffusion-weighted and dynamic contrast-enhanced MR imaging--initial experience.
J. Coolen (2012)
10.1102/1470-7330.2012.0049
Low-dose CT: technique, reading methods and image interpretation
C. Rampinelli (2013)
10.1016/j.lungcan.2013.08.005
Imaging in pleural mesothelioma: a review of the 11th International Conference of the International Mesothelioma Interest Group.
S. Armato (2013)
10.1016/j.jtcvs.2012.09.030
Patterns of recurrence and second primary lung cancer in early-stage lung cancer survivors followed with routine computed tomography surveillance.
F. Lou (2013)
Meta-analysis of the efficacy of positron emission tomography with F-18-fluorodeoxyglucose in lung tumors
D Hellwig (2000)
10.2214/AJR.05.1228
Software volumetric evaluation of doubling times for differentiating benign versus malignant pulmonary nodules.
M. Revel (2006)
10.1186/2050-7771-1-4
Lung cancer screening: from imaging to biomarker
D. Xiang (2012)
10.1016/j.ejrad.2013.11.012
Lung nodule detection in a high-risk population: comparison of magnetic resonance imaging and low-dose computed tomography.
G. Sommer (2014)
10.1148/RADIOL.2363041310
Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging.
S. S. Shim (2005)
10.1016/S1470-2045(13)70293-6
CT screening for lung cancer: countdown to implementation.
J. Field (2013)
10.1102/1470-7330.2013.0009
Dual-energy CT imaging of thoracic malignancies
L. Zhang (2013)
10.1159/000091528
CT and MRI of Lung Cancer
F. Laurent (2006)
In this article, we can find the recent opinions about imaging in pleural mesothelioma
Ultrasound vs . CT in detecting
V Bandi
10.1016/j.diii.2013.05.007
Management strategy of pulmonary nodule in 2013.
M. Lederlin (2013)
10.1378/chest.12-2355
Methods for staging non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.
G. Silvestri (2013)



This paper is referenced by
10.1097/RCT.0000000000000319
Dual-Energy Computed Tomography Virtual Monoenergetic Imaging of Lung Cancer: Assessment of Optimal Energy Levels
M. Kaup (2016)
10.2214/AJR.12.9424
Image quality assessment of standard- and low-dose chest CT using filtered back projection, adaptive statistical iterative reconstruction, and novel model-based iterative reconstruction algorithms.
V. Vardhanabhuti (2013)
Multimodal and Non-Invasive Imaging Techniques for a Multiparametric Characterization of Tumor Biology
Christian Hundshammer (2019)
10.1016/j.ijrobp.2020.01.018
To biopsy or not to biopsy: A matched cohort analysis of early stage lung cancer treated with stereotactic radiation with or without histologic confirmation.
A. Dautruche (2020)
10.1007/978-3-319-28652-5_2
Atlas and Anatomy of SPECT/CT
E. E. Kim (2016)
10.21037/qims.2018.08.05
Improved image quality of low-dose CT combining with iterative model reconstruction algorithm for response assessment in patients after treatment of malignant tumor.
X. Xin (2018)
10.1016/j.lfs.2019.03.041
TRIM59 promotes gefitinib resistance in EGFR mutant lung adenocarcinoma cells.
Zhilei Cui (2019)
10.1007/978-3-319-22581-4_6
The Radiologist’s Approach to CUP
P. Kazmierczak (2016)
10.1016/j.jtho.2016.06.003
Comprehensive Clinical Staging for Resectable Lung Cancer: Clinicopathological Correlations and the Role of Brain MRI
Jordyn Vernon (2016)
10.12957/RHUPE.2015.17933
Câncer de pulmão: atualização da terapêutica cirúrgica
E. Saito (2015)
10.1016/j.clinbiochem.2016.11.015
A quantitative immunoassay for lung cancer biomarker CIZ1b in patient plasma
D. Coverley (2017)
Semantic Scholar Logo Some data provided by SemanticScholar